- Previous Close
19.05 - Open
19.00 - Bid 18.95 x --
- Ask 19.00 x --
- Day's Range
18.85 - 19.05 - 52 Week Range
18.60 - 28.20 - Volume
163,277 - Avg. Volume
164,442 - Market Cap (intraday)
2.794B - Beta (5Y Monthly) 0.15
- PE Ratio (TTM)
29.69 - EPS (TTM)
0.64 - Earnings Date Apr 30, 2025 - May 5, 2025
- Forward Dividend & Yield 0.30 (1.58%)
- Ex-Dividend Date Sep 5, 2024
- 1y Target Est
--
OK Biotech Co., Ltd. develops, manufactures, markets, and sells blood glucose monitoring devices and related homecare medical products in Taiwan and internationally. It also provides glucometers and blood glucose test strips; nebulizer, portable nebulizer, mesh nebulizer, and test strips; and personal sound amplifiers. OK Biotech Co., Ltd. was founded in 2006 and is headquartered in Hsinchu City, Taiwan.
www.okbiotech.comRecent News: 4155.TW
View MorePerformance Overview: 4155.TW
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4155.TW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4155.TW
View MoreValuation Measures
Market Cap
2.79B
Enterprise Value
3.28B
Trailing P/E
29.69
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.67
Price/Book (mrq)
1.12
Enterprise Value/Revenue
1.97
Enterprise Value/EBITDA
15.96
Financial Highlights
Profitability and Income Statement
Profit Margin
5.63%
Return on Assets (ttm)
1.06%
Return on Equity (ttm)
4.28%
Revenue (ttm)
1.67B
Net Income Avi to Common (ttm)
93.97M
Diluted EPS (ttm)
0.64
Balance Sheet and Cash Flow
Total Cash (mrq)
290.5M
Total Debt/Equity (mrq)
28.05%
Levered Free Cash Flow (ttm)
-443.16M